Overview
Jan Steyaert is a professor at Vrije Universiteit Brussel and director of the Structural Biology Brussels lab at Vrije Universiteit Brussel, as well as Deputy-Director of the Structural Biology Research Center of Flanders Institute for Biotechnology. He founded Confo Therapeutics in 2015 as a spin-off from his lab at Vrije Universiteit Brussel and Flanders Institute for Biotechnology, based on the ConfoBody technology he developed for stabilizing GPCRs in pharmacologically relevant conformations. He is also a co-founder of Ablynx and Biotalys, and won the Jacob and Louise Gabbay Award in Biotechnology and Medicine in 2022.
Career history
In the news
- What does the future of health look like? 🩺❤️ Find out on October 19, when researchers, health innovators, entrepreneurs and policymakers come together at TheMerode for the specialised business track Health & Human at the Flanders Technology & Innovation Festival. Expect inspiring insights, real-world cases, and conversations that spark new connections across the health and innovation ecosystem. Vrije Universiteit Brussel is deeply integrated throughout the programme, with our experts taking the stage in panels and keynotes in the
- Don't wait for the future of your sector to arrive. Build it at the Flanders Technology & Innovation Festival in Brussels, together with Vrije Universiteit Brussel. Two days. Three sectors. One place to meet the people, ideas and innovations driving your sector forward. On October 19 and 20, FTI Brussels brings professionals together at TheMerode for three specialised business tracks: 🏙️ Circular & City: How can we make our cities more circular, resilient and liveable? ❤️ Health & Human: How can technology, innovation and
Related profiles
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.